ARCHIVES

Cancer Control Progress, Challenge Mark ACS Observance

This article is from The Cancer Letter archive.

Vol. 17 No. 40 | October 18, 1991

Download PDF Visit The Full Archive

Related Articles

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Agents Not Indicated In Curative Setting.

August 8, 2008

Ambitious Radiation Oncology Research Plan Calls For “Concentrated Efforts” In Emerging Areas

June 12, 1987

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986